Xin Wang, Danyun Ruan, Yuping Sun, Zuoxing Niu, Jieer Ying, Lixin Wan, Yanqiao Zhang, Kangsheng Gu, Huiting Xu, Hai Hu, Linzhi Lu, Wei Gong, Yuhua Liu, Chuanqi Chao, Shu qiang Song, Shengfeng Li, Ruihua Xu. "A phase Ib/IIa study of BAT8010+BAT1006, an anti-HER2 monoclonal antibody-exatecan conjugate combined with an ADCC-enhanced HER2 mAb in patients with advanced solid tumors: Results from the HER2-positive GC/GEJC cohort.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16034